Improving prostate cancer diagnosis using advanced MRI technology
MRI Virtual Pathology of the Prostate: Multi-center multi-vendor application and validation
This study is testing a new MRI tool that helps doctors better spot prostate cancer by looking closely at prostate tissue, making it easier to find cancer and avoid unnecessary biopsies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Qmis, LLC NIH-funded |
| Lab location | 1 site (Crete, United States) |
| Project ID | NIH-10650383 on NIH RePORTER |
What this research studies
This research focuses on enhancing the accuracy of prostate cancer screening through a new MRI analysis tool called MR Virtual Pathology of the Prostate (MVP2). The tool utilizes advanced imaging techniques to analyze prostate tissue composition, helping to identify cancerous areas more effectively than traditional methods. By quantifying different tissue types within the prostate, the research aims to reduce unnecessary biopsies and improve the detection of clinically significant prostate cancer. The study involves collaboration across multiple centers to validate the effectiveness of this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are men at elevated risk for prostate cancer, particularly those with high prostate-specific antigen (PSA) levels.
Not a fit: Patients who do not have elevated PSA levels or those who have already been diagnosed with prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and less invasive prostate cancer screening methods, ultimately improving patient outcomes.
How similar studies have performed: Previous research has shown promising results with advanced MRI techniques in cancer detection, indicating that this approach has potential for success.
Where this research is happening
Crete, United States
- Qmis, LLC — Crete, United States (Active)
Researchers
- Principal investigator: Oto, Aytekin — Qmis, LLC
- Study coordinator: Oto, Aytekin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.